Quanome Technologies, Inc. QNME
0.74
(0.07)
(8.64%)
as of 25 Sep
- Market cap
- $26.9M
- P/E
- 0.0×
Follow QNME
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.36 | 0.96 | 0.75 | 1.00 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(3.83) | (4.73) | (38.41) | 16.87 | |
P/B ratio |
2.26 | 2.73 | 1.43 | 1.77 | |
Price to Tangible BV |
2.59 | 2.91 | 1.48 | 1.81 | |
EV/Sales |
0.16 | 0.75 | 0.70 | 0.95 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(1.04) | (2.83) | (3.11) | (4.86) | |
EV/FCF |
(0.85) | (2.54) | (2.79) | (4.31) | |
Quick Ratio |
0.67 | 1.43 | 1.31 | 2.15 | |
Current Ratio |
1.06 | 1.52 | 2.03 | 4.27 | |
Net Debt/EBITDA |
3.98 | 3.63 | 3.85 | 0.43 | |
Debt/Assets |
8.06% | 2.50% | 1.62% | 0.75% | |
Debt/Equity |
0.41 | 0.07 | 0.03 | 0.01 | |
Asset Turnover |
1.51 | 1.35 | 1.36 | 1.74 | |
Operating CF/Net income |
1.88 | 2.96 | 0.29 | 10.03 | |
Capex/Depreciation |
(1.53) | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
34.25% | 37.66% | 44.41% | 181.48% | |
Intangible Assets out of Total Assets |
0.03 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
0.00% | 5.89% | 8.30% | 86.51% | |
Graham Net Nets |
(0.20) | 0.17 | 0.52 | 0.53 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(81.18%) | (46.51%) | (47.19%) | (38.57%) | |
Free Cash Flow Yield |
(50.71%) | (30.89%) | (33.27%) | (22.07%) | |
Revenue per Share |
1.27 | 0.41 | 0.36 | 0.04 | |
Operating CF per Share |
(0.22) | (0.27) | (0.02) | 0.04 | |
Capex per Share |
(0.08) | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.30) | (0.27) | (0.02) | 0.04 | |
Cash per Share |
0.64 | 0.31 | 0.08 | 0.04 | |
Shareholders Equity per Share |
0.38 | 0.47 | 0.62 | 0.40 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.38 | 0.47 | 0.62 | 0.40 | |
Free Cash Flow |
(2.27) | (4.02) | (0.45) | 1.43 | |
Working Capital |
0.61 | 5.16 | 10.78 | 13.05 | |
Capital Expenditures |
(0.59) | — | — | — | |
Net Current Asset Value |
(1.28) | 3.31 | 9.09 | 12.88 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.06 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(9.29%) | (22.25%) | (22.58%) | 10.73% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
2.46 | 5.97 | 6.98 | 4.53 | |
Average Payables |
1.20 | 1.74 | 2.20 | 1.31 | |
Average Inventory |
— | — | 0.07 | 0.12 | |
Average Assets |
11.80 | 14.72 | 17.07 | 13.86 | |
Average Common Equity |
1.74 | 5.29 | 6.91 | 7.18 |
Columns are period end dates